Effect of dofetilide on QT dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure-Reference-Cited by-同舟云学术

Effect of dofetilide on QT dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure

Published:2002-03 Issue:2 Volume:4 Page:201-206
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Brendorp Bente¹,Elming Hanne¹,Jun Li¹,Køber Lars²,Torp-Pedersen Christian¹,

Affiliation:

1. Department of Cardiology; Copenhagen University Hospital; Gentofte Denmark

2. Department of Cardiology; Copenhagen University Hospital, Rigshospitalet; Denmark

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Antiarrhythmic drug effects on QT interval dispersion in patients undergoing electropharmacologic testing for ventricular tachycardia and fibrillation;Gillis;Am J Cardiol,1998

2. UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells;Gwilt;J Pharmacol Exp Ther,1991

3. Influence of dofetilide on QT-interval duration and dispersion at various heart rates during exercise in humans;Demolis;Circulation,1996

4. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris;Sedgwick;Am J Cardiol,1992

5. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group;Torp-Pedersen;N Engl J Med,1999

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QT Dispersion and Drug-Induced Torsade de Pointes;Cureus;2021-01-25

2. Pharmacological interventions for heart failure in people with chronic kidney disease;Cochrane Database of Systematic Reviews;2020-02-27

3. Facilitation of IKr current by some hERG channel blockers suppresses early afterdepolarizations;Journal of General Physiology;2019-01-23

4. Dofetilide induced torsade de pointes: Mechanism, risk factors and management strategies;Indian Heart Journal;2014-11

5. Discovery of 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: Integrated Drug-Design and Structure-Activity Relationships for Orally Potent, Metabolically Stable and Potential-Risk Reduced Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist as Antianxiety Drug;Chemical Biology & Drug Design;2009-10